Targeted agents for second-line treatment of advanced hepatocellular carcinoma
2019-01-01 Personeni, N; Pressiani, T; Bozzarelli, S; Rimassa, L
Activity and safety of NGR-hTNF, a selective vascular-targeting agent, in previously treated patients with advanced hepatocellular carcinoma
2010-01-01 Santoro, A; Pressiani, T; Citterio, G; Rossoni, G; Donadoni, G; Pozzi, F; Rimassa, L; Personeni, N; Bozzarelli, S; Rossoni, G; Colombi, S; De Braud, Fg; Caligaris-Cappio, F; Lambiase, A; Bordignon, C
A phase II randomized dose escalation trial of sorafenib in patients with advanced hepatocellular carcinoma
2013-01-01 Rimassa, L.; Pressiani, T.; Boni, C.; Carnaghi, C.; Rota Caremoli, E.; Fagiuoli, S.; Foa, P.; Salvagni, S.; Cortesi, E.; Tronconi, M. C.; Personeni, N.; Bozzarelli, S.; Banzi, M. C.; Fanello, S.; Romano Lutman, F.; Giordano, L.; Santoro, A.
Pharmacological inactivation of DNA repair to improve response to immunotherapy: The Arethusa trial in metastatic colorectal cancer
2019-01-01 Marsoni, S; Germano, G; Bianchi, As; Pietrantonio, F; Personeni, N; Amatu, A; Bonoldi, E; Valtorta, E; Barault, L; Di Nicolantonio, F; De Braud, F; Rimassa, L; Santoro, A; Ghezzi, S; Cassingena, A; Marrapese, G; Lupica, L; Siravegna, G; Rospo, G; Martino, C; Lazzari, L; Luraghi, P; Amirouchene-Angelozzi, N; Bardelli, A; Siena, S
Fatal Infusion Reaction to Cetuximab: The Need for Predictive Risk Factors and Safer Patient Selection
2011-01-01 Tronconi, Mc; Sclafani, F; Rimassa, L; Carnaghi, C; Personeni, N; Santoro, A
Activity and safety of NGR-hTNF, a selective vascular-targeting agent, in previously treated patients with advanced hepatocellular carcinoma
2010-01-01 Santoro, A.; Pressiani, T.; Citterio, G.; Rossoni, G.; Donadoni, G.; Pozzi, F.; Rimassa, L.; Personeni, N.; Bozzarelli, S.; Rossoni, G.; Colombi, S.; De Braud, F. G.; Caligaris Cappio, F.; Lambiase, A.; Bordignon, C.
Temozolomide treatment alters mismatch repair and boosts mutational burden in tumor and blood of colorectal cancer patients
2022-01-01 Crisafulli, Giovanni; Sartore-Bianchi, Andrea; Lazzari, Luca; Pietrantonio, Filippo; Amatu, Alessio; Macagno, Marco; Barault, Ludovic; Cassingena, Andrea; Bartolini, Alice; Luraghi, Paolo; Mauri, Gianluca; Battuello, Paolo; Personeni, Nicola; Zampino, Maria Giulia; Pessei, Valeria; Vitiello, Pietro Paolo; Tosi, Federica; Idotta, Laura; Morano, Federica; Valtorta, Emanuele; Bonoldi, Emanuela; Germano, Giovanni; Di Nicolantonio, Federica; Marsoni, Silvia; Siena, Salvatore; Bardelli, Alberto
Fatal Infusion Reaction to Cetuximab : The Need for Predictive Risk Factors and Safer Patient Selection
2011-01-01 Tronconi, M. C.; Sclafani, F.; Rimassa, L.; Carnaghi, C.; Personeni, N.; Santoro, A.
Advanced colorectal liver metastases and surgery after preoperative chemotherapy : is response-based selection enough?
2011-01-01 Personeni, N.; Torzilli, G.; Santoro, A.
Cabozantinib plus atezolizumab for the treatment of advanced hepatocellular carcinoma: shedding light on the preclinical rationale and clinical trials
2022-01-01 Cammarota, Antonella; Zanuso, Valentina; D'Alessio, Antonio; Pressiani, Tiziana; Personeni, Nicola; Rimassa, Lorenza
NASH limits anti-tumour surveillance in immunotherapy-treated HCC
2021-01-01 Pfister, Dominik; Núñez, Nicolás Gonzalo; Pinyol, Roser; Govaere, Olivier; Pinter, Matthias; Szydlowska, Marta; Gupta, Revant; Qiu, Mengjie; Deczkowska, Aleksandra; Weiner, Assaf; Müller, Florian; Sinha, Ankit; Friebel, Ekaterina; Engleitner, Thomas; Lenggenhager, Daniela; Moncsek, Anja; Heide, Danijela; Stirm, Kristin; Kosla, Jan; Kotsiliti, Eleni; Leone, Valentina; Dudek, Michael; Yousuf, Suhail; Inverso, Donato; Singh, Indrabahadur; Teijeiro, Ana; Castet, Florian; Montironi, Carla; Haber, Philipp K; Tiniakos, Dina; Bedossa, Pierre; Cockell, Simon; Younes, Ramy; Vacca, Michele; Marra, Fabio; Schattenberg, Jörn M; Allison, Michael; Bugianesi, Elisabetta; Ratziu, Vlad; Pressiani, Tiziana; D'Alessio, Antonio; Personeni, Nicola; Rimassa, Lorenza; Daly, Ann K; Scheiner, Bernhard; Pomej, Katharina; Kirstein, Martha M; Vogel, Arndt; Peck-Radosavljevic, Markus; Hucke, Florian; Finkelmeier, Fabian; Waidmann, Oliver; Trojan, Jörg; Schulze, Kornelius; Wege, Henning; Koch, Sandra; Weinmann, Arndt; Bueter, Marco; Rössler, Fabian; Siebenhüner, Alexander; Dosso, Sara De; Mallm, Jan-Philipp; Umansky, Viktor; Jugold, Manfred; Luedde, Tom; Schietinger, Andrea; Schirmacher, Peter; Emu, Brinda; Augustin, Hellmut G; Billeter, Adrian; Müller-Stich, Beat; Kikuchi, Hiroto; Duda, Dan G; Kütting, Fabian; Waldschmidt, Dirk-Thomas; Ebert, Matthias Philip; Rahbari, Nuh; Mei, Henrik E; Schulz, Axel Ronald; Ringelhan, Marc; Malek, Nisar; Spahn, Stephan; Bitzer, Michael; Ruiz De Galarreta, Marina; Lujambio, Amaia; Dufour, Jean-Francois; Marron, Thomas U; Kaseb, Ahmed; Kudo, Masatoshi; Huang, Yi-Hsiang; Djouder, Nabil; Wolter, Katharina; Zender, Lars; Marche, Parice N; Decaens, Thomas; Pinato, David J; Rad, Roland; Mertens, Joachim C; Weber, Achim; Unger, Kristian; Meissner, Felix; Roth, Susanne; Jilkova, Zuzana Macek; Claassen, Manfred; Anstee, Quentin M; Amit, Ido; Knolle, Percy; Becher, Burkhard; Llovet, Josep M; Heikenwalder, Mathias
Which choice of therapy when many are available? Current systemic therapies for advanced hepatocellular carcinoma
2020-01-01 Personeni, N; Pressiani, T; Rimassa, L
A Phase II Randomized Dose Escalation Trial of Sorafenib in Patients with Advanced Hepatocellular Carcinoma
2013-01-01 Rimassa, L; Pressiani, T; Boni, C; Carnaghi, C; Rota Caremoli, E; Fagiuoli, S; Foa, P; Salvagni, S; Cortesi, E; Tronconi, Mc; Personeni, N; Bozzarelli, S; Banzi, Mc; Fanello, S; Lutman, Fr; Giordano, L; Santoro, A
Which choice of therapy when many are available? - Current systemic therapies for advanced hepatocellular carcinoma
In corso di stampa Personeni, N; Pressiani, T; Rimassa, L
Phase III trial comparing protracted intravenous fluorouracil infusion alone or with yttrium-90 resin microspheres radioembolization for liver-limited metastatic colorectal cancer refractory to standard chemotherapy
2010-01-01 Hendlisz, A.; Van Den Eynde, M.; Peeters, M.; Maleux, G.; Lambert, B.; Vannoote, J.; De Keukeleire, K.; Verslype, C.; Defreyne, L.; Van Cutsem, E.; Delatte, P.; Delaunoit, T.; Personeni, N.; Paesmans, M.; Van Laethem, J.; Flamen, P.
COVID-19 and liver cancer clinical trials: not everything is lost
2020-01-01 D'Alessio, A; Personeni, N; Pressiani, T; Bozzarelli, S; Smiroldo, V; Simonelli, M; Lleo, A; Santoro, A; Rimassa, L
Impact of older age in patients receiving atezolizumab and bevacizumab for hepatocellular carcinoma
2022-01-01 Vithayathil, Mathew; D'Alessio, Antonio; Fulgenzi, Claudia A M; Nishida, Naoshi; Schönlein, Martin; Von Felden, Johann; Schulze, Kornelius; Wege, Henning; Saeed, Anwaar; Wietharn, Brooke; Hildebrand, Hannah; Wu, Linda; Ang, Celina; Marron, Thomas U; Weinmann, Arndt; Galle, Peter R; Bettinger, Dominik; Bengsch, Bertram; Vogel, Arndt; Balcar, Lorenz; Scheiner, Bernhard; Lee, Pei-Chang; Huang, Yi-Hsiang; Amara, Suneetha; Muzaffar, Mahvish; Naqash, Abdul Rafeh; Cammarota, Antonella; Personeni, Nicola; Pressiani, Tiziana; Pinter, Matthias; Cortellini, Alessio; Kudo, Masatoshi; Rimassa, Lorenza; Pinato, David J; Sharma, Rohini
Prognostic value of the neutrophil-to-lymphocyte ratio in hepatocellular carcinoma: an exploratory analysis from the second-line ARQ 197-215 study
2017-01-01 Personeni, N; Giordano, L; Abbadessa, G; Porta, C; Borbath, I; Daniele, B; Salvagni, S; Van Laethem, Jl; Van Vlierberghe, H; Trojan, J; De Toni, En; Weiss, A; Miles, S; Gasbarrini, A; Lencioni, M; Lamar, Me; Wang, Y; Shuster, D; Schwartz, B; Santoro, A; Rimassa, L
Effect of Comorbidities in Stage II/III Colorectal Cancer Patients Treated With Surgery and Neoadjuvant/Adjuvant Chemotherapy: A Single-Center, Observational Study
2018-01-01 Baretti, M; Rimassa, L; Personeni, N; Giordano, L; Tronconi, Mc; Pressiani, T; Bozzarelli, S; Santoro, A
Biomarkers in Hepatocellular Carcinoma-Letter
2012-01-01 Personeni, N; Rimassa, L; Santoro, A
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Targeted agents for second-line treatment of advanced hepatocellular carcinoma | 1-gen-2019 | Personeni, N; Pressiani, T; Bozzarelli, S; Rimassa, L | |
| Activity and safety of NGR-hTNF, a selective vascular-targeting agent, in previously treated patients with advanced hepatocellular carcinoma | 1-gen-2010 | Santoro, A; Pressiani, T; Citterio, G; Rossoni, G; Donadoni, G; Pozzi, F; Rimassa, L; Personeni, N; Bozzarelli, S; Rossoni, G; Colombi, S; De Braud, Fg; Caligaris-Cappio, F; Lambiase, A; Bordignon, C | |
| A phase II randomized dose escalation trial of sorafenib in patients with advanced hepatocellular carcinoma | 1-gen-2013 | Rimassa, L.; Pressiani, T.; Boni, C.; Carnaghi, C.; Rota Caremoli, E.; Fagiuoli, S.; Foa, P.; Salvagni, S.; Cortesi, E.; Tronconi, M. C.; Personeni, N.; Bozzarelli, S.; Banzi, M. C.; Fanello, S.; Romano Lutman, F.; Giordano, L.; Santoro, A. | |
| Pharmacological inactivation of DNA repair to improve response to immunotherapy: The Arethusa trial in metastatic colorectal cancer | 1-gen-2019 | Marsoni, S; Germano, G; Bianchi, As; Pietrantonio, F; Personeni, N; Amatu, A; Bonoldi, E; Valtorta, E; Barault, L; Di Nicolantonio, F; De Braud, F; Rimassa, L; Santoro, A; Ghezzi, S; Cassingena, A; Marrapese, G; Lupica, L; Siravegna, G; Rospo, G; Martino, C; Lazzari, L; Luraghi, P; Amirouchene-Angelozzi, N; Bardelli, A; Siena, S | |
| Fatal Infusion Reaction to Cetuximab: The Need for Predictive Risk Factors and Safer Patient Selection | 1-gen-2011 | Tronconi, Mc; Sclafani, F; Rimassa, L; Carnaghi, C; Personeni, N; Santoro, A | |
| Activity and safety of NGR-hTNF, a selective vascular-targeting agent, in previously treated patients with advanced hepatocellular carcinoma | 1-gen-2010 | Santoro, A.; Pressiani, T.; Citterio, G.; Rossoni, G.; Donadoni, G.; Pozzi, F.; Rimassa, L.; Personeni, N.; Bozzarelli, S.; Rossoni, G.; Colombi, S.; De Braud, F. G.; Caligaris Cappio, F.; Lambiase, A.; Bordignon, C. | |
| Temozolomide treatment alters mismatch repair and boosts mutational burden in tumor and blood of colorectal cancer patients | 1-gen-2022 | Crisafulli, Giovanni; Sartore-Bianchi, Andrea; Lazzari, Luca; Pietrantonio, Filippo; Amatu, Alessio; Macagno, Marco; Barault, Ludovic; Cassingena, Andrea; Bartolini, Alice; Luraghi, Paolo; Mauri, Gianluca; Battuello, Paolo; Personeni, Nicola; Zampino, Maria Giulia; Pessei, Valeria; Vitiello, Pietro Paolo; Tosi, Federica; Idotta, Laura; Morano, Federica; Valtorta, Emanuele; Bonoldi, Emanuela; Germano, Giovanni; Di Nicolantonio, Federica; Marsoni, Silvia; Siena, Salvatore; Bardelli, Alberto | |
| Fatal Infusion Reaction to Cetuximab : The Need for Predictive Risk Factors and Safer Patient Selection | 1-gen-2011 | Tronconi, M. C.; Sclafani, F.; Rimassa, L.; Carnaghi, C.; Personeni, N.; Santoro, A. | |
| Advanced colorectal liver metastases and surgery after preoperative chemotherapy : is response-based selection enough? | 1-gen-2011 | Personeni, N.; Torzilli, G.; Santoro, A. | |
| Cabozantinib plus atezolizumab for the treatment of advanced hepatocellular carcinoma: shedding light on the preclinical rationale and clinical trials | 1-gen-2022 | Cammarota, Antonella; Zanuso, Valentina; D'Alessio, Antonio; Pressiani, Tiziana; Personeni, Nicola; Rimassa, Lorenza | |
| NASH limits anti-tumour surveillance in immunotherapy-treated HCC | 1-gen-2021 | Pfister, Dominik; Núñez, Nicolás Gonzalo; Pinyol, Roser; Govaere, Olivier; Pinter, Matthias; Szydlowska, Marta; Gupta, Revant; Qiu, Mengjie; Deczkowska, Aleksandra; Weiner, Assaf; Müller, Florian; Sinha, Ankit; Friebel, Ekaterina; Engleitner, Thomas; Lenggenhager, Daniela; Moncsek, Anja; Heide, Danijela; Stirm, Kristin; Kosla, Jan; Kotsiliti, Eleni; Leone, Valentina; Dudek, Michael; Yousuf, Suhail; Inverso, Donato; Singh, Indrabahadur; Teijeiro, Ana; Castet, Florian; Montironi, Carla; Haber, Philipp K; Tiniakos, Dina; Bedossa, Pierre; Cockell, Simon; Younes, Ramy; Vacca, Michele; Marra, Fabio; Schattenberg, Jörn M; Allison, Michael; Bugianesi, Elisabetta; Ratziu, Vlad; Pressiani, Tiziana; D'Alessio, Antonio; Personeni, Nicola; Rimassa, Lorenza; Daly, Ann K; Scheiner, Bernhard; Pomej, Katharina; Kirstein, Martha M; Vogel, Arndt; Peck-Radosavljevic, Markus; Hucke, Florian; Finkelmeier, Fabian; Waidmann, Oliver; Trojan, Jörg; Schulze, Kornelius; Wege, Henning; Koch, Sandra; Weinmann, Arndt; Bueter, Marco; Rössler, Fabian; Siebenhüner, Alexander; Dosso, Sara De; Mallm, Jan-Philipp; Umansky, Viktor; Jugold, Manfred; Luedde, Tom; Schietinger, Andrea; Schirmacher, Peter; Emu, Brinda; Augustin, Hellmut G; Billeter, Adrian; Müller-Stich, Beat; Kikuchi, Hiroto; Duda, Dan G; Kütting, Fabian; Waldschmidt, Dirk-Thomas; Ebert, Matthias Philip; Rahbari, Nuh; Mei, Henrik E; Schulz, Axel Ronald; Ringelhan, Marc; Malek, Nisar; Spahn, Stephan; Bitzer, Michael; Ruiz De Galarreta, Marina; Lujambio, Amaia; Dufour, Jean-Francois; Marron, Thomas U; Kaseb, Ahmed; Kudo, Masatoshi; Huang, Yi-Hsiang; Djouder, Nabil; Wolter, Katharina; Zender, Lars; Marche, Parice N; Decaens, Thomas; Pinato, David J; Rad, Roland; Mertens, Joachim C; Weber, Achim; Unger, Kristian; Meissner, Felix; Roth, Susanne; Jilkova, Zuzana Macek; Claassen, Manfred; Anstee, Quentin M; Amit, Ido; Knolle, Percy; Becher, Burkhard; Llovet, Josep M; Heikenwalder, Mathias | |
| Which choice of therapy when many are available? Current systemic therapies for advanced hepatocellular carcinoma | 1-gen-2020 | Personeni, N; Pressiani, T; Rimassa, L | |
| A Phase II Randomized Dose Escalation Trial of Sorafenib in Patients with Advanced Hepatocellular Carcinoma | 1-gen-2013 | Rimassa, L; Pressiani, T; Boni, C; Carnaghi, C; Rota Caremoli, E; Fagiuoli, S; Foa, P; Salvagni, S; Cortesi, E; Tronconi, Mc; Personeni, N; Bozzarelli, S; Banzi, Mc; Fanello, S; Lutman, Fr; Giordano, L; Santoro, A | |
| Which choice of therapy when many are available? - Current systemic therapies for advanced hepatocellular carcinoma | In corso di stampa | Personeni, N; Pressiani, T; Rimassa, L | |
| Phase III trial comparing protracted intravenous fluorouracil infusion alone or with yttrium-90 resin microspheres radioembolization for liver-limited metastatic colorectal cancer refractory to standard chemotherapy | 1-gen-2010 | Hendlisz, A.; Van Den Eynde, M.; Peeters, M.; Maleux, G.; Lambert, B.; Vannoote, J.; De Keukeleire, K.; Verslype, C.; Defreyne, L.; Van Cutsem, E.; Delatte, P.; Delaunoit, T.; Personeni, N.; Paesmans, M.; Van Laethem, J.; Flamen, P. | |
| COVID-19 and liver cancer clinical trials: not everything is lost | 1-gen-2020 | D'Alessio, A; Personeni, N; Pressiani, T; Bozzarelli, S; Smiroldo, V; Simonelli, M; Lleo, A; Santoro, A; Rimassa, L | |
| Impact of older age in patients receiving atezolizumab and bevacizumab for hepatocellular carcinoma | 1-gen-2022 | Vithayathil, Mathew; D'Alessio, Antonio; Fulgenzi, Claudia A M; Nishida, Naoshi; Schönlein, Martin; Von Felden, Johann; Schulze, Kornelius; Wege, Henning; Saeed, Anwaar; Wietharn, Brooke; Hildebrand, Hannah; Wu, Linda; Ang, Celina; Marron, Thomas U; Weinmann, Arndt; Galle, Peter R; Bettinger, Dominik; Bengsch, Bertram; Vogel, Arndt; Balcar, Lorenz; Scheiner, Bernhard; Lee, Pei-Chang; Huang, Yi-Hsiang; Amara, Suneetha; Muzaffar, Mahvish; Naqash, Abdul Rafeh; Cammarota, Antonella; Personeni, Nicola; Pressiani, Tiziana; Pinter, Matthias; Cortellini, Alessio; Kudo, Masatoshi; Rimassa, Lorenza; Pinato, David J; Sharma, Rohini | |
| Prognostic value of the neutrophil-to-lymphocyte ratio in hepatocellular carcinoma: an exploratory analysis from the second-line ARQ 197-215 study | 1-gen-2017 | Personeni, N; Giordano, L; Abbadessa, G; Porta, C; Borbath, I; Daniele, B; Salvagni, S; Van Laethem, Jl; Van Vlierberghe, H; Trojan, J; De Toni, En; Weiss, A; Miles, S; Gasbarrini, A; Lencioni, M; Lamar, Me; Wang, Y; Shuster, D; Schwartz, B; Santoro, A; Rimassa, L | |
| Effect of Comorbidities in Stage II/III Colorectal Cancer Patients Treated With Surgery and Neoadjuvant/Adjuvant Chemotherapy: A Single-Center, Observational Study | 1-gen-2018 | Baretti, M; Rimassa, L; Personeni, N; Giordano, L; Tronconi, Mc; Pressiani, T; Bozzarelli, S; Santoro, A | |
| Biomarkers in Hepatocellular Carcinoma-Letter | 1-gen-2012 | Personeni, N; Rimassa, L; Santoro, A |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile
Scopri
Tipologia
- 1 Articolo su rivista71162
- 2 Contributo in volume (Capitolo ...1
- 7 Altro1
Data di pubblicazione
- In corso di stampa66
- 2020 - 202616403
- 2010 - 201922952
- 2000 - 200918285
- 1990 - 19998873
- 1980 - 19893844
- 1970 - 1979711
- 1965 - 196930
Editore
- MDPI965
- Elsevier Ltd746
- Elsevier B.V.640
- MDPI AG497
- Elsevier386
- Springer316
- John Wiley and Sons Inc314
- Multidisciplinary Digital Publish...296
- Springer Science and Business Med...288
- Elsevier Inc.261
Rivista
- ACTA BIO-MEDICA DE L'ATENEO PARMENSE933
- PLOS ONE381
- ANNALI DELLA FACOLTÀ DI MEDICINA ...348
- SCIENTIFIC REPORTS272
- AREA262
- INTERNATIONAL JOURNAL OF MOLECULA...192
- DOCTOR. OS183
- ACTA BIOMEDICA181
- NUTRIENTS179
- PHYSICAL REVIEW. B, CONDENSED MAT...169
Serie
- KEY ENGINEERING MATERIALS1
Keyword
- Humans2902
- Female1593
- Male1490
- Middle Aged900
- Adult893
- Aged757
- Animals652
- Italy585
- Medicine (all)464
- COVID-19451
Lingua
- eng42929
- ita9076
- fre232
- spa124
- ger99
- und61
- enm49
- rus41
- grc33
- por33
Accesso al fulltext
- no fulltext57853
- reserved8054
- open3765
- partially open822
- restricted667
- embargoed2
- mixed1